(VIANEWS) – Brandywine Realty Trust (BDN), Tekla Healthcare Investors (HQH), Seagate Technology (STX) are the highest payout ratio stocks on this list.
We have congregated information concerning stocks with the highest payout ratio as yet. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Brandywine Realty Trust (BDN)
542.86% Payout Ratio
Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia and Austin markets. Organized as a real estate investment trust (REIT), we own, develop, lease and manage an urban, town center and transit-oriented portfolio comprising 160 properties and 22.6 million square feet as of September 30, 2023 which excludes assets held for sale. Our purpose is to shape, connect and inspire the world around us through our expertise, the relationships we foster, the communities in which we live and work, and the history we build together.
Earnings Per Share
As for profitability, Brandywine Realty Trust has a trailing twelve months EPS of $-1.15.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -13.35%.
Moving Average
Brandywine Realty Trust’s value is below its 50-day moving average of $4.81 and higher than its 200-day moving average of $4.54.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 133.3% and positive 25% for the next.
Sales Growth
Brandywine Realty Trust’s sales growth is 0.4% for the ongoing quarter and 4.2% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 35.8%, now sitting on 437.84M for the twelve trailing months.
2. Tekla Healthcare Investors (HQH)
147.71% Payout Ratio
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Earnings Per Share
As for profitability, Tekla Healthcare Investors has a trailing twelve months EPS of $1.09.
PE Ratio
Tekla Healthcare Investors has a trailing twelve months price to earnings ratio of 15.21. Meaning, the purchaser of the share is investing $15.21 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.1%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.1%, now sitting on 10.29M for the twelve trailing months.
Volume
Today’s last reported volume for Tekla Healthcare Investors is 125575 which is 35.42% below its average volume of 194456.
Yearly Top and Bottom Value
Tekla Healthcare Investors’s stock is valued at $16.58 at 02:23 EST, under its 52-week high of $17.94 and way above its 52-week low of $14.31.
Moving Average
Tekla Healthcare Investors’s value is below its 50-day moving average of $17.12 and above its 200-day moving average of $16.44.
3. Seagate Technology (STX)
98.59% Payout Ratio
Seagate Technology Holdings plc provides data storage technology and solutions in Singapore, the United States, the Netherlands, and internationally. It provides mass capacity storage products, including enterprise nearline hard disk drives (HDDs), enterprise nearline solid state drives (SSDs), enterprise nearline systems, video and image HDDs, and network-attached storage drives. The company also offers legacy applications comprising Mission Critical HDDs and SSDs; external storage solutions under the Seagate Ultra Touch, One Touch, and Expansion product lines, as well as under the LaCie brand name; desktop drives; notebook drives, DVR HDDs, and gaming SSDs. In addition, it provides Lyve edge-to-cloud mass capacity platform. The company sells its products primarily to OEMs, distributors, and retailers. Seagate Technology Holdings plc was founded in 1978 and is based in Dublin, Ireland.
Earnings Per Share
As for profitability, Seagate Technology has a trailing twelve months EPS of $-3.51.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 20, 2024, the estimated forward annual dividend rate is 2.8 and the estimated forward annual dividend yield is 3.02%.
Volume
Today’s last reported volume for Seagate Technology is 1756640 which is 32.29% below its average volume of 2594410.
Revenue Growth
Year-on-year quarterly revenue growth declined by 17.6%, now sitting on 6.47B for the twelve trailing months.
4. Ashland (ASH)
51.2% Payout Ratio
Ashland Global Holdings Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. Ashland Global Holdings Inc. offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, Delaware.
Earnings Per Share
As for profitability, Ashland has a trailing twelve months EPS of $2.91.
PE Ratio
Ashland has a trailing twelve months price to earnings ratio of 33.26. Meaning, the purchaser of the share is investing $33.26 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.83%.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
1’s EBITDA is 1.
